Generalizability

Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess 2005; 9(38):iii-x, 1.
PMID: 16181564 

Begg CB, Engstrom PF. Eligibility and extrapolation in cancer clinical trials. J Clin Oncol 1987; 5(6):962-968.
PMID: 3585451

Bonell C, Oakley A, Hargreaves J, Strange V, Rees R. Assessment of generalisability in trials of health interventions: suggested framework and systematic review. BMJ 2006; 333(7563):346-349.
PMID: 16902217 

Bornhoft G, Maxion-Bergemann S, Wolf U, Kienle GS, Michalsen A, Vollmar HC, Gilbertson S, Matthiessen PF. Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity. BMC Med Res Methodol 2006; 6:56.
PMID: 17156475 

Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997; 315(7115):1059.
PMID: 9366735

Dans AL, Dans LF, Guyatt GH, Richardson S. Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA 1998; 279(7):545-549.
PMID: 9480367 

Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH. The uncertainty principle and industry-sponsored research. Lancet 2000; 356(9230):635-638.
PMID: 10968436

Glasgow R, Green L, Klesges L, Abrams D, Fisher E, Goldstein M, Hayman L, Ockene J, Orleans C. External Validity: We need to do more. Ann Behav Med 2006; 31(2):105-108. Glasgow RE, Green LW, Ammerman A. A focus on external validity. Eval Health Prof 2007; 30(2):115-117.
PMID: 17476025

Glasziou P, Guyatt GH, Dans AL, Dans LF, Straus S, Sackett DL. Applying the results of trials and systematic reviews to individual patients. ACP J Club 1998; 129(3):A15-A16.
PMID: 9825009 

Green LW, Glasgow RE. Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Eval Health Prof 2006; 29(1):126-153.
PMID: 16510882

Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268(11):1417-1422.
PMID: 1512909

Howard SC, Algra A, Warlow CP, Rothwell PM. Potential consequences for recruitment, power, and external validity of requirements for additional risk factors for eligibility in randomized controlled trials in secondary prevention of stroke. Stroke 2006; 37(1):209-215.
PMID: 16339480

King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, Sibbald B, Lai R. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials. Health Technol Assess 2005; 9(35):1-iv.
PMID: 16153352 

Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318(26):1728-1733.
PMID: 3374545 

Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA 1994; 272(24):1932-1938.
PMID: 7990246

Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005; 365(9453):82-93.
PMID: 15639683

Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials 2006; 1(1):e9.
PMID: 16871331 

 

Page last edited: 05 May 2009